Here’s why Pfizer is revising its revenue forecasts down | Curated by Alerts360
The drugmaker revised its revenue guidance for 2025, saying it now expects $62 billion in revenue for the year. Stay informed with the latest market updates, stock movements, and financial news to make timely decisions.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0